issue

May 10, 2024

Volume 20 Number 9

A special EuroPCR 2024 issue of EuroIntervention beginning with an expert consensus from the Valve Academic Research Consortium for High Bleeding Risk on defining the complexities of TAVI-related high bleeding risk; a debate on systematic OCT use in PCI; outcomes by sex from the ISCHEMIA trial; results from the DECISION QFR RCT on whether providing either QFR- or FFR-based data affected Heart Team decision-making on the mode of revascularisation for patients with multivessel disease; using controlled antegrade and retrograde subintimal tracking in contemporary CTO PCI; from the OCEAN-TAVI registry, a look at valve performance of SAPIEN 3 Ultra RESILIA; predictors of late lumen loss after drug-coated balloon angioplasty; the incidence, predictors and clinical impact of subclinical new-onset atrial fibrillation after TAVI; balloon-expandable vs self-expanding stents in coarctation of aorta; trends and procedure-related events in treating severe renovascular hypertension; and a viewpoint on Impella-assisted PCI; the evolution of EuroIntervention; and more...

Snapshot

Debate

We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons
Ali ZA, Shin D, Chaturvedi A, Waksman R
10.4244/EIJ-E-24-00008
free

Expert Consensus

Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document
Garot P, Morice M, Angiolillo DJ, Cabau JR, Park D, Van Mieghem NM, Collet J, Leon M, Sengottuvelu G, Neylon A, ten Berg JM, Mylotte D, Tchétché D, Krucoff MW, Reardon MJ, Piazza N, Mack M, Généreux P, Makkar R, Hayashida K, Ohno Y, Mochizuki S, Shirai Y, Matsumara R, Jin Y, Webb JG, Cutlip DE, Chen M, Spitzer E, Mehran R, Capodanno D
10.4244/EIJ-D-23-01020
free

Original research

Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial
Gaudino M, Alexander J, Sandner S, Harik L, Kim J, Stone G, Rahouma M, O'Gara P, Bhatt D, Redfors B
10.4244/EIJ-D-24-00011
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial
Asano T, Tanigaki T, Hoshino M, Yasunaga M, Nonaka H, Emori H, Katagiri Y, Miyazaki Y, Sotomi Y, Kogame N, Kuramitsu S, Saito A, Miyata K, Takaoka Y, Kanie T, Yamasaki M, Yoshino K, Wakabayashi N, Ouchi K, Kodama H, Shiina Y, Tamaki R, Nishihata Y, Masuda K, Suzuki T, Reiber JH, Okamura T, Higuchi Y, Kakuta T, Misumi H, Abe K, Komiyama N, Tanabe K, Matsuo H, QFR investigators obotD
10.4244/EIJ-D-23-00674
Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry
Yamamoto M, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Otsuka T, Asami M, Watanabe Y, Hayashida K, OCEAN-TAVI investigators obot
10.4244/EIJ-D-23-00996
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation
Nuche J, Soliman F, Chavarria J, Okoh A, Alvarado Mora H, Nault I, Natarajan M, Russo M, Philippon F, Rodés-Cabau J
10.4244/EIJ-D-23-01014

Editorial comment

Editorial comment

Research Correspondence

Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial
Sadeghipour P, Pouraliakbar HR, Farrashi M, Habibi Khorasani S, Mohebbi B, Iranian M, Babaei M, Forouzannia SM, Afrooghe A, Shafe O, Firouzi A, Hosseini F, Khalilipur E, Khajali Z, Saedi S, Abdi S, Moosavi J, Haulon S, Fraisse A
10.4244/EIJ-D-23-00846
Procedural trends and event rates in severe renovascular hypertension
Earle WB, Li S, Yang S, Krawisz A, Aronow HD, Parikh SA, Juraschek SP, Cluett JL, Schermerhorn ML, Carroll BJ, Secemsky EA
10.4244/EIJ-D-23-01030

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved